US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist

3.820
-0.020-0.52%

Trading May 21 10:03 ET

229.50MMarket Cap-3638P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-75.52%-17.86M

-22.50%-43.06M

25.79%-8.31M

-40.53%-12.91M

-80.43%-11.67M

-22.61%-10.18M

-95.72%-35.15M

-207.86%-11.2M

-19.45%-9.18M

-51.69%-6.47M

Net income from continuing operations

-31.54%-14.87M

-22.20%-52.37M

-28.22%-16.5M

-20.98%-12.96M

-14.37%-11.61M

-23.86%-11.31M

57.40%-42.86M

-54.10%-12.87M

-174.47%-10.71M

83.46%-10.15M

Operating gains losses

--48K

--1.35M

----

Depreciation and amortization

-15.38%44K

8.88%184K

-20.41%39K

-9.09%40K

35.90%53K

40.54%52K

4,125.00%169K

1,533.33%49K

4,300.00%44K

--39K

Other non cash items

--268K

--884K

----

Change In working capital

-17,045.83%-4.07M

-3.01%3.87M

643.73%6.05M

-294.25%-878K

-148.32%-1.33M

158.54%24K

1,237.58%3.99M

-80.01%814K

111.06%452K

383.76%2.76M

-Change in prepaid assets

74.86%-226K

-121.71%-369K

118.72%67K

222.30%1.5M

-155.41%-1.03M

-163.49%-899K

143.80%1.7M

-186.06%-358K

61.62%-1.22M

275.38%1.87M

-Change in payables and accrued expense

-481.29%-3.83M

71.80%4.4M

373.90%6.01M

-239.56%-2.37M

-126.05%-249K

173.90%1.01M

-38.95%2.56M

-65.33%1.27M

289.29%1.7M

950.55%956K

-Change in other current assets

179.55%35K

48.91%-70K

45.76%-32K

35.71%19K

51.85%-13K

32.31%-44K

-878.57%-137K

-5,800.00%-59K

--14K

---27K

-Change in other current liabilities

-15.79%-44K

32.12%-93K

127.03%10K

20.59%-27K

-11.76%-38K

-18.75%-38K

---137K

---37K

---34K

Cash from discontinued investing activities

Operating cash flow

-75.52%-17.86M

-22.50%-43.06M

25.79%-8.31M

-40.53%-12.91M

-80.43%-11.67M

-22.61%-10.18M

-95.72%-35.15M

-207.86%-11.2M

-19.45%-9.18M

-51.69%-6.47M

Investing cash flow

Cash flow from continuing investing activities

78.05%-9.2M

-538.10%-171.67M

-139.02%-48.81M

-264.53%-92M

25.94%11.06M

-722.26%-41.93M

137.63%39.19M

-103.98%-20.42M

159.42%55.92M

146,516.67%8.79M

Net PPE purchase and sale

---11K

88.82%-18K

60.00%-14K

95.06%-4K

--0

-302.50%-161K

-34.62%-35K

-912.50%-81K

-500.00%-36K

Net investment purchase and sale

78.08%-9.19M

-536.27%-171.65M

-139.36%-48.79M

-264.28%-92M

25.43%11.06M

-723.71%-41.93M

137.80%39.35M

-104.16%-20.39M

159.51%56M

--8.82M

Cash from discontinued investing activities

Investing cash flow

78.05%-9.2M

-538.10%-171.67M

-139.02%-48.81M

-264.53%-92M

25.94%11.06M

-722.26%-41.93M

137.63%39.19M

-103.98%-20.42M

159.42%55.92M

146,516.67%8.79M

Financing cash flow

Cash flow from continuing financing activities

7.11M

3,784.13%151.75M

596.32%29.13M

46,778.33%122.76M

-145K

-98.05%3.91M

41,740.00%4.18M

-100.16%-263K

Net issuance payments of debt

---739K

--30M

----

--0

----

Net common stock issuance

--7.91M

3,114.77%121.9M

-110.28%-390K

----

--0

-97.75%3.79M

126,500.00%3.79M

----

Proceeds from stock option exercised by employees

----

182.61%325K

--0

16,150.00%325K

----

-93.88%115K

638.46%96K

0.00%2K

----

Net other financing activities

---60K

---476K

----

---265K

----

Cash from discontinued financing activities

Financing cash flow

--7.11M

3,784.13%151.75M

596.32%29.13M

46,778.33%122.76M

---145K

--0

-98.05%3.91M

41,740.00%4.18M

-100.16%-263K

----

Net cash flow

Beginning cash position

-48.41%67.12M

6.50%130.1M

-39.63%95.11M

-30.45%77.25M

-28.29%78M

6.50%130.1M

179.06%122.16M

16.01%157.54M

61.41%111.07M

162.67%108.76M

Current changes in cash

61.70%-19.96M

-893.32%-62.98M

-2.00%-27.99M

-61.57%17.86M

-132.61%-751K

-288.88%-52.1M

-89.87%7.94M

-101.17%-27.44M

-30.63%46.47M

-91.60%2.3M

End cash Position

-39.53%47.16M

-48.41%67.12M

-39.63%95.11M

-30.45%77.25M

-28.29%78M

6.50%130.1M

16.01%157.54M

61.41%111.07M

Free cash flow

-75.63%-17.87M

-22.01%-43.09M

25.89%-8.33M

-39.38%-12.91M

-79.43%-11.67M

-22.47%-10.18M

-96.18%-35.31M

-206.63%-11.24M

-20.37%-9.26M

-52.32%-6.5M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-75.52%-17.86M	-22.50%-43.06M	25.79%-8.31M	-40.53%-12.91M	-80.43%-11.67M	-22.61%-10.18M	-95.72%-35.15M	-207.86%-11.2M	-19.45%-9.18M	-51.69%-6.47M
Net income from continuing operations	-31.54%-14.87M	-22.20%-52.37M	-28.22%-16.5M	-20.98%-12.96M	-14.37%-11.61M	-23.86%-11.31M	57.40%-42.86M	-54.10%-12.87M	-174.47%-10.71M	83.46%-10.15M
Operating gains losses	--48K	--1.35M	----	----	----	----	----	----	----	----
Depreciation and amortization	-15.38%44K	8.88%184K	-20.41%39K	-9.09%40K	35.90%53K	40.54%52K	4,125.00%169K	1,533.33%49K	4,300.00%44K	--39K
Other non cash items	--268K	--884K	----	----	----	----	----	----	----	----
Change In working capital	-17,045.83%-4.07M	-3.01%3.87M	643.73%6.05M	-294.25%-878K	-148.32%-1.33M	158.54%24K	1,237.58%3.99M	-80.01%814K	111.06%452K	383.76%2.76M
-Change in prepaid assets	74.86%-226K	-121.71%-369K	118.72%67K	222.30%1.5M	-155.41%-1.03M	-163.49%-899K	143.80%1.7M	-186.06%-358K	61.62%-1.22M	275.38%1.87M
-Change in payables and accrued expense	-481.29%-3.83M	71.80%4.4M	373.90%6.01M	-239.56%-2.37M	-126.05%-249K	173.90%1.01M	-38.95%2.56M	-65.33%1.27M	289.29%1.7M	950.55%956K
-Change in other current assets	179.55%35K	48.91%-70K	45.76%-32K	35.71%19K	51.85%-13K	32.31%-44K	-878.57%-137K	-5,800.00%-59K	--14K	---27K
-Change in other current liabilities	-15.79%-44K	32.12%-93K	127.03%10K	20.59%-27K	-11.76%-38K	-18.75%-38K	---137K	---37K	---34K	---34K
Cash from discontinued investing activities
Operating cash flow	-75.52%-17.86M	-22.50%-43.06M	25.79%-8.31M	-40.53%-12.91M	-80.43%-11.67M	-22.61%-10.18M	-95.72%-35.15M	-207.86%-11.2M	-19.45%-9.18M	-51.69%-6.47M
Investing cash flow
Cash flow from continuing investing activities	78.05%-9.2M	-538.10%-171.67M	-139.02%-48.81M	-264.53%-92M	25.94%11.06M	-722.26%-41.93M	137.63%39.19M	-103.98%-20.42M	159.42%55.92M	146,516.67%8.79M
Net PPE purchase and sale	---11K	88.82%-18K	60.00%-14K	95.06%-4K	--0	--0	-302.50%-161K	-34.62%-35K	-912.50%-81K	-500.00%-36K
Net investment purchase and sale	78.08%-9.19M	-536.27%-171.65M	-139.36%-48.79M	-264.28%-92M	25.43%11.06M	-723.71%-41.93M	137.80%39.35M	-104.16%-20.39M	159.51%56M	--8.82M
Cash from discontinued investing activities
Investing cash flow	78.05%-9.2M	-538.10%-171.67M	-139.02%-48.81M	-264.53%-92M	25.94%11.06M	-722.26%-41.93M	137.63%39.19M	-103.98%-20.42M	159.42%55.92M	146,516.67%8.79M
Financing cash flow
Cash flow from continuing financing activities	7.11M	3,784.13%151.75M	596.32%29.13M	46,778.33%122.76M	-145K	0	-98.05%3.91M	41,740.00%4.18M	-100.16%-263K
Net issuance payments of debt	---739K	--30M	----	----	----	--0	--0	----	----	----
Net common stock issuance	--7.91M	3,114.77%121.9M	-110.28%-390K	----	----	--0	-97.75%3.79M	126,500.00%3.79M	----	----
Proceeds from stock option exercised by employees	----	182.61%325K	--0	16,150.00%325K	----	----	-93.88%115K	638.46%96K	0.00%2K	----
Net other financing activities	---60K	---476K	----	----	----	----	----	----	---265K	----
Cash from discontinued financing activities
Financing cash flow	--7.11M	3,784.13%151.75M	596.32%29.13M	46,778.33%122.76M	---145K	--0	-98.05%3.91M	41,740.00%4.18M	-100.16%-263K	----
Net cash flow
Beginning cash position	-48.41%67.12M	6.50%130.1M	-39.63%95.11M	-30.45%77.25M	-28.29%78M	6.50%130.1M	179.06%122.16M	16.01%157.54M	61.41%111.07M	162.67%108.76M
Current changes in cash	61.70%-19.96M	-893.32%-62.98M	-2.00%-27.99M	-61.57%17.86M	-132.61%-751K	-288.88%-52.1M	-89.87%7.94M	-101.17%-27.44M	-30.63%46.47M	-91.60%2.3M
End cash Position	-39.53%47.16M	-48.41%67.12M	-48.41%67.12M	-39.63%95.11M	-30.45%77.25M	-28.29%78M	6.50%130.1M	6.50%130.1M	16.01%157.54M	61.41%111.07M
Free cash flow	-75.63%-17.87M	-22.01%-43.09M	25.89%-8.33M	-39.38%-12.91M	-79.43%-11.67M	-22.47%-10.18M	-96.18%-35.31M	-206.63%-11.24M	-20.37%-9.26M	-52.32%-6.5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall